Cancer cell biology – metastasis
A92 – A108
- A92: Vascular response during metastasis is organ-specific and regulated by host angiopoietin-2
- A93: Endothelial activation by disseminated dormant tumour cells
- A94: Outcome of patients with primary renal cell cancer metastasising to the tongue, thyroid and skeletal muscle
- A95: Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface
- A96: The coagulative role of Tissue Factor enhances tumour cell survival in the lung by recruitment of macrophages.
- A97: Mutant p53 regulates invasion via integrins and EGFR
- A98: Invasion of metastatic cells into monolayers of endothelial cells analysed directly with shear flow in vitro
- A99: MDM2 links disease progression with motility and invasion in renal cell carcinoma
- A100: Targeting cell spreading as a method of sensitising metastatic tumour cells to TRAIL killing
- A101: Increased incidence of visceral metastases in BRCA defective ovarian cancer patients: an extension of the ovarian BRCAness phenotype
- A102: The chemokine receptor CXCR4 and its ligand CXCL12 sustain a cell-autonomus network in ovarian cancer
- A103: Downregulation of Disabled-2 switches TGF-beta from a tumour suppressor to a tumour promoter
- A104: Oncogenic Ras diverts a host TNF tumour suppressor activity into tumour promoter.
- A105: Matrix Metalloproteinase -8 suppresses breast cancer metastasis
- A106: PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase
- A107: Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice
- A108: Non-invasive optical imaging of the tumour micro-environment within the hollow fibre assay: A model for the evaluation of novel anti-cancer agents
